Lexaria Bioscience Corp expected to post a loss of 13 cents a share - Earnings Preview

Lexaria Bioscience

10/04/2024 12:02

* Lexaria Bioscience Corp  LEXX.OQ   LEXX.O  is expected
to report
results  for the period ending May 31 2024
    * 
    * ​LSEG's mean analyst estimate for Lexaria Bioscience Corp
is for
a loss of 13 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts had risen by
about 41.2%
in the last three months. ​
    * Wall Street's median 12-month price target for Lexaria
Bioscience Corp is $11.00​, above​ its last closing price
of $2.70. ​​​

This summary was machine generated April 10 at 11:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)